Mirati Therapeutics (MRTX) Announces CEO Departure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
- Oppenheimer sees AI software winners as focus shifts to ROI
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
Citi Closes Catalyst Watch on Mirati Therapeutics (MRTX) Citi Closes Catalyst Watch
August 8, 2023 4:08 PM EDTCiti Closes Catalyst Watch on Mirati Therapeutics (NASDAQ: MRTX)
"Expiring Upside 90-Day Catalyst Watch"The analyst comments "This Upside Catalyst Watch call, opened on 10-May-2023, has expired effective immediately and should no longer be relied upon."
... More